197 related articles for article (PubMed ID: 26657054)
1. Dysregulation of the DNA Damage Response and KMT2A Rearrangement in Fetal Liver Hematopoietic Cells.
Nanya M; Sato M; Tanimoto K; Tozuka M; Mizutani S; Takagi M
PLoS One; 2015; 10(12):e0144540. PubMed ID: 26657054
[TBL] [Abstract][Full Text] [Related]
2. MLL rearrangements are induced by low doses of etoposide in human fetal hematopoietic stem cells.
Moneypenny CG; Shao J; Song Y; Gallagher EP
Carcinogenesis; 2006 Apr; 27(4):874-81. PubMed ID: 16377807
[TBL] [Abstract][Full Text] [Related]
3. Environmental and chemotherapeutic agents induce breakage at genes involved in leukemia-causing gene rearrangements in human hematopoietic stem/progenitor cells.
Thys RG; Lehman CE; Pierce LC; Wang YH
Mutat Res; 2015 Sep; 779():86-95. PubMed ID: 26163765
[TBL] [Abstract][Full Text] [Related]
4. Gene rearrangements of MLL and RUNX1 sporadically occur in normal CD34
Harada Y; Shingai N; Ding Y; Sadato D; Hayashi Y; Yamaguchi M; Okuyama Y; Shimoyama T; Ohashi K; Harada H
Cancer Sci; 2020 May; 111(5):1851-1855. PubMed ID: 32216001
[TBL] [Abstract][Full Text] [Related]
5. Assessing acute myeloid leukemia susceptibility in rearrangement-driven patients by DNA breakage at topoisomerase II and CCCTC-binding factor/cohesin binding sites.
Atkin ND; Raimer HM; Wang Z; Zang C; Wang YH
Genes Chromosomes Cancer; 2021 Dec; 60(12):808-821. PubMed ID: 34405474
[TBL] [Abstract][Full Text] [Related]
6. Quercetin alters the DNA damage response in human hematopoietic stem and progenitor cells via TopoII- and PI3K-dependent mechanisms synergizing in leukemogenic rearrangements.
Biechonski S; Gourevich D; Rall M; Aqaqe N; Yassin M; Zipin-Roitman A; Trakhtenbrot L; Olender L; Raz Y; Jaffa AJ; Grisaru D; Wiesmuller L; Elad D; Milyavsky M
Int J Cancer; 2017 Feb; 140(4):864-876. PubMed ID: 27813122
[TBL] [Abstract][Full Text] [Related]
7. DOT1L inhibits SIRT1-mediated epigenetic silencing to maintain leukemic gene expression in MLL-rearranged leukemia.
Chen CW; Koche RP; Sinha AU; Deshpande AJ; Zhu N; Eng R; Doench JG; Xu H; Chu SH; Qi J; Wang X; Delaney C; Bernt KM; Root DE; Hahn WC; Bradner JE; Armstrong SA
Nat Med; 2015 Apr; 21(4):335-43. PubMed ID: 25822366
[TBL] [Abstract][Full Text] [Related]
8. Chlorpyrifos Induces MLL Translocations Through Caspase 3-Dependent Genomic Instability and Topoisomerase II Inhibition in Human Fetal Liver Hematopoietic Stem Cells.
Lu C; Liu X; Liu C; Wang J; Li C; Liu Q; Li Y; Li S; Sun S; Yan J; Shao J
Toxicol Sci; 2015 Oct; 147(2):588-606. PubMed ID: 26198043
[TBL] [Abstract][Full Text] [Related]
9. DNA fragility at the
Cowell IG; Austin CA
Open Biol; 2023 Jan; 13(1):220232. PubMed ID: 36629017
[TBL] [Abstract][Full Text] [Related]
10. In vitro cleavage of the MLL gene by topoisomerase II inhibitor (etoposide) in normal cord and peripheral blood mononuclear cells.
Ishii E; Eguchi M; Eguchi-Ishimae M; Yoshida N; Oda M; Zaitsu M; Fujita I; Miyazaki S; Hamasaki Y; Mizutani S
Int J Hematol; 2002 Jul; 76(1):74-9. PubMed ID: 12138900
[TBL] [Abstract][Full Text] [Related]
11. Etoposide induces MLL rearrangements and other chromosomal abnormalities in human embryonic stem cells.
Bueno C; Catalina P; Melen GJ; Montes R; Sánchez L; Ligero G; García-Pérez JL; Menendez P
Carcinogenesis; 2009 Sep; 30(9):1628-37. PubMed ID: 19587093
[TBL] [Abstract][Full Text] [Related]
12. Expression of MLL-AF4 or AF4-MLL fusions does not impact the efficiency of DNA damage repair.
Castaño J; Herrero AB; Bursen A; González F; Marschalek R; Gutiérrez NC; Menendez P
Oncotarget; 2016 May; 7(21):30440-52. PubMed ID: 27119507
[TBL] [Abstract][Full Text] [Related]
13. Murine Retrovirally-Transduced Bone Marrow Engraftment Models of MLL-Fusion-Driven Acute Myelogenous Leukemias (AML).
Stubbs MC; Krivtsov AV
Curr Protoc Pharmacol; 2017 Sep; 78():14.42.1-14.42.19. PubMed ID: 28892146
[TBL] [Abstract][Full Text] [Related]
14. KMT2A-rearranged infantile acute myeloid leukemia masquerading as juvenile myelomonocytic leukemia.
Kanayama T; Imamura T; Kawabe Y; Osone S; Tahara J; Iwasaki F; Miyagawa N; Goto H; Imashuku S; Hosoi H
Int J Hematol; 2018 Dec; 108(6):665-669. PubMed ID: 30143999
[TBL] [Abstract][Full Text] [Related]
15. Azacitidine successfully maintained the second remission in an infant with KMT2A-rearranged acute lymphoblastic leukemia who relapsed after unrelated cord blood transplantation.
Chijimatsu I; Imanaka Y; Tomizawa D; Eguchi M; Nishimura S; Karakawa S; Miki M; Hamamoto K; Fujita N
Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28675638
[TBL] [Abstract][Full Text] [Related]
16. KMT2A-MAML2 rearrangement emerged and regressed during neuroblastoma therapy without leukemia after 12.8-year follow-up.
Felix CA; Slater DJ; Davenport JW; Yu X; Gregory BD; Li MM; Rappaport EF; Cheung NV
Pediatr Blood Cancer; 2022 Jan; 69(1):e29344. PubMed ID: 34550633
[TBL] [Abstract][Full Text] [Related]
17. The stem cell-specific long noncoding RNA HOXA10-AS in the pathogenesis of KMT2A-rearranged leukemia.
Al-Kershi S; Bhayadia R; Ng M; Verboon L; Emmrich S; Gack L; Schwarzer A; Strowig T; Heckl D; Klusmann JH
Blood Adv; 2019 Dec; 3(24):4252-4263. PubMed ID: 31867596
[TBL] [Abstract][Full Text] [Related]
18.
Schneidawind C; Jeong J; Schneidawind D; Kim IS; Duque-Afonso J; Wong SHK; Iwasaki M; Breese EH; Zehnder JL; Porteus M; Cleary ML
Blood Adv; 2018 Apr; 2(8):832-845. PubMed ID: 29650777
[TBL] [Abstract][Full Text] [Related]
19. Ataxia telangiectasia mutated-dependent regulation of topoisomerase II alpha expression and sensitivity to topoisomerase II inhibitor.
Tamaichi H; Sato M; Porter AC; Shimizu T; Mizutani S; Takagi M
Cancer Sci; 2013 Feb; 104(2):178-84. PubMed ID: 23163762
[TBL] [Abstract][Full Text] [Related]
20. First case of B ALL with KMT2A-MAML2 rearrangement: a case report.
Menu E; Beaufils N; Usseglio F; Balducci E; Lafage Pochitaloff M; Costello R; Gabert J
BMC Cancer; 2017 May; 17(1):363. PubMed ID: 28535805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
